Towards a rational design of solid drug nanoparticles with optimised pharmacological properties

Siccardi, Marco, Martin, Phillip, Smith, Darren, Curley, Paul, McDonald, Tom, Giardiello, Marco, Liptrott, Neill, Rannard, Steven and Owen, Andrew (2016) Towards a rational design of solid drug nanoparticles with optimised pharmacological properties. Journal of Interdisciplinary Nanomedicine, 1 (3). pp. 110-123. ISSN 2058-3273

[img]
Preview
Text (Full text)
Siccardi et al - design of solid drug nanoparticles.pdf - Published Version
Available under License Creative Commons Attribution 4.0.

Download (319kB) | Preview
Official URL: http://dx.doi.org/10.1002/jin2.21

Abstract

Solid drug nanoparticles (SDNs) are a nanotechnology with favourable characteristics to enhance drug delivery and improve the treatment of several diseases, showing benefit for improved oral bioavailability and injectable long-acting medicines. The physicochemical properties and composition of nanoformulations can influence the absorption, distribution, and elimination of nanoparticles; consequently, the development of nanoparticles for drug delivery should consider the potential role of nanoparticle characteristics in the definition of pharmacokinetics. The aim of this study was to investigate the pharmacological behaviour of efavirenz SDNs and the identification of optimal nanoparticle properties and composition. Seventy-seven efavirenz SDNs were included in the analysis. Cellular accumulation was evaluated in HepG2 (hepatic) and Caco-2 (intestinal), CEM (lymphocyte), THP1 (monocyte), and A-THP1 (macrophage) cell lines. Apparent intestinal permeability (Papp) was measured using a monolayer of Caco-2 cells. The Papp values were used to evaluate the potential benefit on pharmacokinetics using a physiologically based pharmacokinetic model. The generated SDNs had an enhanced intestinal permeability and accumulation in different cell lines compared to the traditional formulation of efavirenz. Nanoparticle size and excipient choice influenced efavirenz apparent permeability and cellular accumulation, and this appeared to be cell line dependent. These findings represent a valuable platform for the design of SDNs, giving an empirical background for the selection of optimal nanoparticle characteristics and composition. Understanding how nanoparticle components and physicochemical properties influence pharmacological patterns will enable the rational design of SDNs with desirable pharmacokinetics.

Item Type: Article
Uncontrolled Keywords: Absorption; Caco-2 cells; cellular accumulation; excipients; intestinal permeability; nanoparticles; nanotechnology; PBPK; pharmacokinetics; rational design; solid drug nanoparticle
Subjects: B200 Pharmacology, Toxicology and Pharmacy
B800 Medical Technology
Department: Faculties > Health and Life Sciences > School of Life Sciences > Applied Sciences
Depositing User: Paul Burns
Date Deposited: 05 Dec 2016 09:51
Last Modified: 06 Sep 2017 16:01
URI: http://nrl.northumbria.ac.uk/id/eprint/28792

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics


Policies: NRL Policies | NRL University Deposit Policy | NRL Deposit Licence